Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure
FDA product code QJZ · 4 cleared devices
Class 2
Cardiovascular
- Regulation
- 21 CFR 870.4100
- Review panel
- CV
- Implant
- No
- Life sustaining
- Yes
- Third party review
- No
- GMP exempt
- No
- Clearance span
- 2020-02-21 – 2026-07-31
Extracorporeal circuit and accessories for long-term respiratory/cardiopulmonary failure.
QJZ
2026-07-31
QJZ
2024-09-12
VitalFlow Set with Balance Biosurface
View details →
QJZ
2024-04-15
Novalung ultimate kit (US)
View details →
QJZ
2020-02-21
Novalung System
View details →No matching devices.
Advertisement